Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05592860 · ClinicalTrials.gov registry record · NA

Comparison of Glycemic Control With Smartphone Application

A NA study of Diabetes Mellitus, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05592860 is a NA study of Diabetes Mellitus that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05592860, a NA study of Diabetes Mellitus, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The study is aimed to determine if a smartphone application based weekly glucose monitoring by a care provider is superior to the routine home glucose monitoring by patients in poorly controlled type 2 diabetes mellitus who are on insulin.

Conditions Studied

Interventions

  • DEVICE Mobile application
  • BEHAVIORAL Daily Diary

Study Locations (1)

New York

  • Queens Hospital Center - Jamaica

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-07-10
Est. Completion 2021-12-02
Phase NA

What the Registry Record Tells You About NCT05592860

The ClinicalTrials.gov registry entry for NCT05592860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Mobile application is the first listed.

NCT05592860 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05592860 about?

NCT05592860 is a clinical study titled "Comparison of Glycemic Control With Smartphone Application". The study is aimed to determine if a smartphone application based weekly glucose monitoring by a care provider is superior to the routine home glucose monitoring by patients in poorly controlled type 2 diabetes mellitus who are on insulin.

What is the current status of trial NCT05592860?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-07-10. Estimated completion is 2021-12-02.

What conditions does trial NCT05592860 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT05592860?

The interventions under investigation include: Mobile application (DEVICE), Daily Diary (BEHAVIORAL).

Who is sponsoring clinical trial NCT05592860?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05592860 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.